12:00 AM
 | 
Jul 30, 2001
 |  BioCentury  |  Finance

Analyst picks & changes

Idec Pharmaceuticals Corp. (IDPH), San Diego, Calif.

Business: Cancer, Autoimmune/Inflammation

Dain Rauscher Wessels analyst Andrew Milne raised his rating to...

Read the full 94 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >